NCT00351091View on ClinicalTrials.gov

Risedronate in Postmenopausal Women With Low Bone Density

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
OSTEOPOROSIS, POSTMENOPAUSAL
Interventions
DRUG

RISEDRONATE

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
collaborator

Procter and Gamble

INDUSTRY

lead

Sanofi

INDUSTRY

NCT00351091 - Risedronate in Postmenopausal Women With Low Bone Density | Biotech Hunter | Biotech Hunter